People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ConnectRN, Inc. | — | Other Health Care | Series C | $102.7M | $1.2B | 2018 |
| Somnum Pharma, Inc. | — | Pharmaceuticals | Seed | $2.0M | $7.8M | 2024 |
Michael Jasulavic at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Jasulavic on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Sullivan | 1 | 13 |
| John Pappajohn | 1 | 10 |
| Michael Wood | 1 | 10 |
| Geoffrey Harris | 1 | 4 |
| Orrin Devinsky | 1 | 3 |
| Idriz Limaj | 1 | 2 |
| Peter Biro | 1 | 2 |
| Will Plourde | 1 | 1 |
| Ted Jeanloz | 1 | 1 |
| Agron Ademi | 1 | 1 |
| John Yetimoglu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.